OTHER PUBLICATIONS:
1. | Bourne A. M., Johnson, R.V., Cyril, S. et al. (2018). Scoping review of priority setting of research topics for musculoskeletal conditions. BMJ Open, 8(12):e023962. doi: 10.1136/bmjopen-2018-023962 |
2. | Buchbinder, R, Bourne, A, Latimer, J. et al. (2018). Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Intern Med J. Dec 11. doi: 10.1111/imj.14191 |
1 | Buchbinder R. The formation of the ANZMUSC Clinical Trials Network; lessons learned. ACTA Summit 20018: Building a self-improving healthcare system. 29-30 November 2018, Sydney, Australia |
2 | Maher C. Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. September 2018, Duchenne CTN Establishment meeting, Sydney, Australia |
3 | Buchbinder R. Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. ACTA Impact and Implementation of Clinical Trial Networks. 28 August 2018, Melbourne, Australia |
4 | Buchbinder R. Establishing the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network, 23 August 2018, Southern Denmark University, Odense, Denmark |
5 | Buchbinder R. 2018 Bonica Lecture: Setting the research agenda for improving health care in musculoskeletal disorders. 2018 Australian Pain Society 38thand New Zealand Pain Society Conjoint Annual Scientific Meeting (APS NZPS 2018), 8-11 April 2018, Sydney, Australia (Invited Keynote) |
6 | Buchbinder R. Establishing a Multi-disciplinary Trials Network – what can we learn from others? 2nd Australia New Zealand Alliance of Cardiovascular Trials, 8 Feb 2018, Melbourne, Australia |
7 | Buchbinder R. The future of research funding for musculoskeletal disorders in Australia Annual chiropractic researchers’ forum, COCA and Chiro Australia, 13 October 2017, Melbourne, Australia (Invited Plenary) |
8 | Buchbinder R. The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Cochrane Back Workshop, International Back and Neck Pain Research Forum, 12-15 September 2017, Oslo, Norway |
9 | Buchbinder R. Australian initiatives for Cochrane and clinical trials. BMJD 5th World Congress, 31 August to 3 Sept 2017, Gold Coast, Australia |
10 | Buchbinder R. ANZMUSC. Osteoarthritis Summit, 30 May 2017, Sydney, Australia |
11 | Bourne AM, Buchbinder R. Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network: How and why we began. SHPA Research Think Tank, June 2016, Melbourne, Australia |
12 | Bourne AM, Whittle, S, Richards B, Maher C, Buchbinder R. Musculoskeletal clinical trials in Australia: What trials are being performed, who is funding them and where are they being published? 54th ARA and RHPA Annual Scientific Meeting, May 2013, Hobart, Australia |
1. | Taylor W, Buchbinder R, for the ANZMUSC Clinical Trials Network. Development of a multi-attribute tool for setting priorities for trials in the musculoskeletal field. A project of the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. 7thAnnual NHMRC Symposium on Research Translation, Sydney, Australia, 27-28 November 2018 |
2. | Bourne AM, Johnston RV, Cyril S, Briggs AM, Clavisi O, Duque G, Harris IA, Hill C, Hiller C, Kamper SJ, Latimer J, Lawson A, Lin C-W C, Maher CG, Perriman D, Richards BL, Smitham P, Taylor WJ, Whittle S, Buchbinder R. A systematic review of priority-setting of research topics for musculoskeletal conditions. 7th Annual NHMRC Symposium on Research Translation, Sydney, Australia, 27-28 November 2018 |
Membership is open to individuals, professional organisations, consumer organisations, health insurers, and policy makers.
For any queries regarding ANZMUSC please contact us using the form below.
© 2021 ANZMUSC